000			02021 a2200589 4500
005			20250516094057.0
264		0	_c20121010
008			201210s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2012.05.025 _2doi
040			_aNLM _beng _cNLM
100	1		_aYuan, Qianying
245	0	0	_aA new protoapigenone analog RY10-4 induces apoptosis and suppresses invasion through the PI3K/Akt pathway in human breast cancer. _h[electronic resource]
260			_bCancer letters _cNov 2012
300			_a210-20 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBlotting, Western
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aPhosphatidylinositol 3-Kinase _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aPyrones _xpharmacology
650	0	4	_aS Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aCai, Shaoxin
700	1		_aZhang, Xuenong
700	1		_aLiu, Ziwei
700	1		_aLi, Zhaoming
700	1		_aLuo, Xuelai
700	1		_aXiong, Chaomei
700	1		_aWang, Jianping
700	1		_aHu, Junbo
700	1		_aRuan, Jinlan
773	0		_tCancer letters _gvol. 324 _gno. 2 _gp. 210-20
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2012.05.025 _zAvailable from publisher's website
999			_c21826017 _d21826017